Disruption of embryonic ROCK signalling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
More about Open Access at the CrickAuthors list
Kate E Bailey Guy A MacGowan Simon Tual-Chalot Lauren Phillips Tim J Mohun Deborah J Henderson Helen M Arthur Simon D Bamforth Helen M PhillipsAbstract
Sarcomeric disarray is a hallmark of gene mutations in patients with Hypertrophic Cardiomyopathy (HCM). However, it is unknown when detrimental sarcomeric changes first occur and whether they originate in the developing embryonic heart. Furthermore, Rho Kinase (ROCK) is a serine threonine protein kinase that is critical for regulating the function of several sarcomeric proteins and therefore, our aim was to determine if disruption of ROCK signalling during the earliest stages of heart development would disrupt the integrity of sarcomeres altering heart development and function. Using a mouse model in which the function of ROCK is specifically disrupted in embryonic cardiomyocytes we demonstrate a progressive cardiomyopathy that first appeared as sarcomeric disarray during cardiogenesis. This led to abnormalities in the structure of embryonic ventricular wall and compensatory cardiomyocyte hypertrophy during foetal development. This sarcomeric disruption and hypertrophy persisted throughout adult life, triggering left ventricular concentric hypertrophy with systolic dysfunction, and re-activation of foetal gene expression and cardiac fibrosis, all typical features of HCM. Taken together, our findings establish a novel mechanism for the developmental origin of the sarcomeric phenotype of HCM and suggest that variants in the ROCK genes or disruption of ROCK signalling could, in part, contribute to its pathogenesis.
Journal details
Journal JCI insight
Volume 4
Issue number 8
Pages e125172
Available online
Publication date
Full text links
Publisher website (DOI) 10.1172/jci.insight.125172
Figshare View on figshare
Europe PubMed Central 30835717
Pubmed 30835717
Keywords
Related topics
Type of publication